The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.

The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.
Three years after the coronavirus pandemic made residency interviews virwtual, some programs have begun to do in-person interviews again this year, to the delight of some resident candidates and faculty.
People with bilateral cochlear implantation have diminished perception of musical attributes, which limits their emotional response when listening
Distinguished otolaryngologists were honored and generations of physicians connected at the 2024 Triological Society Combined Sections Meeting in West Palm Beach, Florida.
This article provides a brief foundational understanding of generative AI and describes examples of its current and potential uses in healthcare, as well as the experience of some otolaryngologists in their early adoption of generative AI programs designed to help ease the burdensome task of documentation.
Dr. Pensak reminisces about his career, his time as Triological Society executive vice president, and what comes next.
Short-term mission trips—where physicians go in, help, and then leave—address the immediate burden of patient care, whereas longer trips—where physicians create programs and train local physicians to take over after they have gone—address the ongoing need for care.
Traditional approaches to laryngotracheal reconstruction have relied on open transcervical approaches. With the growth of endoscopic techniques, there have been multiple advances in minimally invasive procedures to augment airway stenosis in pediatric patients.
While the economics of running an otolaryngology practice seem to get more challenging each year, financiers see plenty of opportunity for profit.
Our hope is that ENTtoday provides a forum for discussion of different points of view, thereby empowering all of us to succeed in the practice of otolaryngology.